Depression and anxiety in axial spondyloarthritis
Hong Kong Bulletin on Rheumatic Diseases · 2018
DOI: 10.2478/hkbrd-2018-0001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hong Kong Bulletin on Rheumatic Diseases, 2018. Verfasst von Cynthia Yan-yan Chan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Depression
Abstract (Originalsprache)
Axial spondyloarthritis (SpA) is a spectrum of chronic inflammatory rheumatologic diseases commonly presenting with symptoms of inflammatory back pain, peripheral joint pain, and fatigue. When compared to the general population, patients with SpA have higher prevalence of depression and anxiety symptoms. Poor psychological status is associated with worse disease activity, poorer functional status, poor treatment adherence, and unhealthy lifestyle choices such as cigarette smoking. The Chinese-bilingual Hospital Anxiety and Depression Scale (HADS) is a validated tool to screen depression and anxiety in patients with axial SpA. The cytokine theory of depression may explain emerging evidence on the mutually beneficial effects of antidepressants on disease outcomes and anti-tumor necrosis factor α (TNFα) therapy on psychological status.
Zitieren
APA
Chan, C. Y. (2018). Depression and anxiety in axial spondyloarthritis. Hong Kong Bulletin on Rheumatic Diseases. https://doi.org/10.2478/hkbrd-2018-0001
Vancouver
Chan CY. Depression and anxiety in axial spondyloarthritis. Hong Kong Bulletin on Rheumatic Diseases. 2018. doi:10.2478/hkbrd-2018-0001
BibTeX
@article{Chan2018,
author = {Chan, Cynthia Yan-yan},
title = {Depression and anxiety in axial spondyloarthritis},
journal = {Hong Kong Bulletin on Rheumatic Diseases},
year = {2018},
doi = {10.2478/hkbrd-2018-0001}
}
EUVIMED